142 filings
Page 5 of 8
6-K
w9lffo2hd6 m0
21 Aug 17
Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares
12:00am
6-K
7sof 839lx5x3qei8uu
21 Aug 17
Current report (foreign)
12:00am
6-K
ppw0g9b18
16 Aug 17
Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares
12:00am
6-K
52tatdc67ww1gfit
15 Aug 17
Intec Pharma Announces Proposed Public Offering of Ordinary Shares
12:00am
6-K
a3k5aheya6xn50l28n
9 Aug 17
Current report (foreign)
12:00am
6-K
kiiqv 313to1vikhgq41
3 Aug 17
Intec Pharma Reports Clinical Results from Phase I Trial of Accordion Pill for Cannabinoid Therapies
12:00am
6-K
ignvxh6j
27 Jul 17
Current report (foreign)
12:00am
6-K
xpxmjpzy1ijxupfe80h
19 Jul 17
Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa
12:00am
6-K
rrg 7cndu
10 Jul 17
Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer
12:00am
6-K
ueya7gj 1midce
1 Jun 17
Intec Pharma to Participate at Upcoming June Conferences
12:00am
6-K
1qfkbfb 4r65
1 Jun 17
Current report (foreign)
12:00am
6-K
su7vvhgk
25 May 17
Current report (foreign)
12:00am
6-K
hcc9cjas84w
24 May 17
Intec Pharma Granted U.S. Patent for Accordion Pill™ Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms
12:00am
6-K
lgf3oorplz 5i3l
3 May 17
Intec Pharma Announces CEO Change
12:00am
6-K
1wd3 ghqwnxkwvtq0l
27 Apr 17
Notice of Special General Meeting of Shareholders
12:00am
6-K
fxjuhicg z3cbr2
19 Apr 17
Notice of Special General Meeting of Shareholders
12:00am
6-K
4gt7dtet9sn
11 Apr 17
Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman
12:00am
6-K
omvox780so0m2
7 Apr 17
Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results
12:00am
6-K
b6aut94odjt gr7bj6pi
29 Mar 17
Intec Pharma Provides Update on Phase III ACCORDANCE Study of the Accordion Pill Carbidopa/Levodopa in Parkinson’s Disease Patients
12:00am
6-K
w3zo05 864iy
23 Mar 17
Current report (foreign)
12:00am